Contact
Please use this form to send email to PR contact of this press release:
CohBar Announces First Subjects Dosed in its Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
TO:
Please use this form to send email to PR contact of this press release:
CohBar Announces First Subjects Dosed in its Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
TO: